透過您的圖書館登入
IP:3.135.190.101
  • 期刊

Regulation of Blood Glucose Level by Kainic Acid in Mice: Involvement of Glucocorticoid System and Non-NMDA Receptors

本篇文章尚未正式出版,請點選「加入追蹤」跟進後續出版資訊!

摘要


Kainic acid (KA) is a well-known excitatory neurotoxic substance. In the present study, effects of KA-injected intraperitoneally (i.p.), intracerebroventricularly (i.c.v.) or intrathecally (i.t.) on the blood glucose level were investigated in ICR mice. We found that KA administered i.p., i.c.v. or i.t. increased the blood glucose and corticosterone levels, suggesting that KA-induced hyperglycemia appeared to be due to increased blood corticosterone level. In support of this finding, adrenalectomy (ADX) causes a reduction of KA-induced hyperglycemia and neuronal cell death in CA3 regions of the hippocampus. In addition, pretreatment with i.c.v. or i.t. in-jection of 6-cyano-7-nitroquinoxaline-2, 3-dione; a non-N-methyl-D-aspartate (NMDA) receptor blocker (CNQX) attenuated the i.p. and i.c.v. administered KA-induced hyperglycemia. KA administered i.c.v. caused an elevation of the blood corticosterone level whereas the plasma insulin level was reduced. Moreover, i.c.v. pretreatment with CNQX inhibited the decrease of plasma insulin level induced by KA i.c.v. injection, whereas the KA-induced plasma corticosterone level was further enhanced by CNQX pretreatment. Our results suggest that KA administered systemically or centrally produces hyperglycemia. A glucocorticoid (GC) system appears to be involved in KA-induced hyperglycemia. Furthermore, central non-NMDA receptors may be responsible for KA-induced hyperglycemia.

參考文獻


Anderson, R.E.,Tan, W.K.,Martin, H.S.,Meyer, F.B.(1999).Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra.Stroke.30,160-170.
Ben-Ari, Y.(1985).Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy.Neuroscience.14,375-403.
Benveniste, H.(1991).The excitotoxin hypothesis in relation to cerebral ischemia..Cerebrovasc. Brain Metab. Rev..3,213-245.
Bleakman, D.,Lodge, D.(1998).Neuropharmacology of AMPA and kainate receptors.Neuropharmacology.37,1187-1204.
Bodnar, I.,Banky, Z.,Zelena, D.,Halasz, B.(2009).Glutamate receptor antagonist infused into the hypothalamic suprachiasmatic nuclei interferes with the diurnal fluctuations in plasma prolactin and corticosterone levels and injected into the mesencephalic dorsal raphe nucleus attenuates the suckling stimulus-induced release of prolactin of the rat..Brain Res. Bull..80,9-16.

延伸閱讀